This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Lemonade (LMND) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
After losing some value lately, a hammer chart pattern has been formed for Lemonade (LMND), indicating that the stock has found support. This, combined with an upward trend in earnings estimate revisions, could lead to a trend reversal for the stock in the near term.
Reasons Why Lemonade (LMND) Stock is an Attractive Pick Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from an improvement in continued shift in the mix of underlying products toward higher value policies and installment fees and a robust capital position.
Down -40.31% in 4 Weeks, Here's Why Lemonade (LMND) Looks Ripe for a Turnaround
by Zacks Equity Research
The heavy selling pressure might have exhausted for Lemonade (LMND) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Down -43.44% in 4 Weeks, Here's Why Lemonade (LMND) Looks Ripe for a Turnaround
by Zacks Equity Research
Lemonade (LMND) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Compared to Estimates, Lemonade (LMND) Q2 Earnings: A Look at Key Metrics
by Zacks Equity Research
The headline numbers for Lemonade (LMND) give insight into how the company performed in the quarter ended June 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Lemonade (LMND) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Lemonade (LMND) delivered earnings and revenue surprises of 5.83% and 7.13%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Can Lower Costs Aid Lincoln National (LNC) in Q2 Earnings?
by Zacks Equity Research
Lincoln National's (LNC) Q2 results are expected to reflect the benefits of a solid Group Protection segment and a reduced expense level, partly offset by declining term product sales.
Prudential (PRU) to Report Q2 Earnings: What to Expect
by Zacks Equity Research
Prudential's (PRU) Q2 results are likely to reflect lower net investment spread results, underwriting results and fee income, offset by higher service & other revenues and fixed income reinvestment rates.
Assurant (AIZ) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
Assurant's (AIZ) second-quarter performance is likely to benefit from organic growth from strong sales in Global Automotive, improved yields on fixed maturity securities, higher average insured values and premium rates.
Mid Penn Bancorp (MPB) Lags Q2 Earnings Estimates
by Zacks Equity Research
Mid Penn Bancorp (MPB) delivered earnings and revenue surprises of -2.86% and 2.27%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
Lemonade (LMND) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release
by Zacks Equity Research
Lemonade (LMND) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Lemonade (LMND) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Lemonade (LMND) closed the most recent trading day at $23.37, moving +1.04% from the previous trading session.
Lemonade (LMND) Soars 15.6%: Is Further Upside Left in the Stock?
by Zacks Equity Research
Lemonade (LMND) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Are Finance Stocks Lagging Federal Agricultural Mortgage (AGM) This Year?
by Zacks Equity Research
Here is how Federal Agricultural Mortgage (AGM) and Lemonade (LMND) have performed compared to their sector so far this year.
Here's Why Investors May Consider Betting on Assurant (AIZ) Now
by Zacks Equity Research
Assurant (AIZ) stands to gain from improved Connected Living business, well-diversified business, rise in invested assets, favorable growth estimates and a solid capital position.
Here's Why Investing in Lemonade (LMND) Stock is Prudent Now
by Zacks Equity Research
Lemonade (LMND) stands to gain from growth on premium placed with third-party insurance companies, interest rates on investment balances and improvement in the average policy value.
ProAssurance (PRA) and Caresyntax Unite for Better Health Outcome
by Zacks Equity Research
ProAssurance (PRA) partners with Caresyntax to make surgeries smarter using AI tools and reduce claim costs for the insurer.
Allstate (ALL) Continues Auto Rate Hikes to Combat Inflation
by Zacks Equity Research
Allstate (ALL) reports estimated catastrophe losses of $699 million after taxes in May.
Aflac (AFL) Rises 28% in a Year: More Room for Growth Ahead?
by Zacks Equity Research
Aflac's (AFL) cost-saving initiatives are helping it to reduce expenses and boost margins.
Are Finance Stocks Lagging Federal Agricultural Mortgage (AGM) This Year?
by Zacks Equity Research
Here is how Federal Agricultural Mortgage (AGM) and Lemonade (LMND) have performed compared to their sector so far this year.
AIG Sells 74.75M Corebridge Shares in Secondary Offering
by Zacks Equity Research
AIG generates gross proceeds of $1.2 billion before deductions from the secondary offering of Corebridge shares.
CNO Financial (CNO) Subsidiary Launches New Accident Insurance
by Zacks Equity Research
The Accident Insurance product from CNO Financial's (CNO) subsidiary, Washington National, has some competitive features, which differentiate it from other products offered in the market.
AIG Seeks to Sell 65M Corebridge Shares in Secondary Offering
by Zacks Equity Research
American International (AIG) will receive all the net proceeds from the secondary offering of Corebridge shares.
Aegon (AEG) Concludes EUR 200M Stock Repurchase Program
by Zacks Equity Research
Utilizing the buyback program, Aegon (AEG) repurchases a total of 46.8 million common shares.
AIG Subsidiary Corebridge to Pay $400M In Special Dividend
by Zacks Equity Research
American International's (AIG) subsidiary Corebridge will also give its regular quarterly dividend of 23 cents per share.